Which cosmetics stock is a better buy? By StockNews


[ad_1]

© Reuters. elf Beauty vs Revlon: which cosmetics stock is a better buy?

Efforts by cosmetic companies to develop quality, natural cosmetics and increase market reach through advertising and e-commerce platforms have helped the industry stay afloat amid the pandemic. With the easing of travel restrictions and increased consumer spending, the emerging small-cap companies in this space, elf Beauty (NYSE 🙂 and Revlon (REV), are well positioned to generate solid returns over the years. next months. But which of these titles is the best buy now? Learn more to find out. Self Beauty, Inc. (ELF) and Revlon, Inc. (REV) are two leading companies in the global cosmetics industry. ELF is a multi-brand beauty company providing cruelty-free cosmetics and beauty products for eyes, lips, and facial care products. It has a market capitalization of $ 1.61 billion. On the other hand, with a market capitalization of $ 611.72 million, REV manufactures, markets and sells beauty and personal care products which include color cosmetics, hair dyes, beauty tools, perfumes, skin care, antiperspirant deodorants and beauty care products. Both companies sell their products through specialty cosmetic stores, retailers, e-commerce platforms and independent distributors.

Mask warrants and travel restrictions led the cosmetics industry to experience an 8% year-over-year sales decline last year. However, the consumer shift towards organic products and new beauty trends have helped the industry rebound this year. In addition, the increase in advertising and e-commerce sales is driving the growth of the industry.

Rising consumer spending and increased foot traffic in brick-and-mortar stores are expected to drive the industry’s sales growth this holiday season. The global cosmetics market is expected to grow at 5.3% CAGR and reach $ 463.50 billion by 2027. Thus, ELF and REV are expected to benefit.

Continue reading on StockNews

Disclaimer: Fusion media would like to remind you that the data contained in this site is not necessarily real time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by the exchanges but rather by the market makers, and therefore the prices may not be accurate and may differ from the actual market price, which means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media assumes no responsibility for any business losses that you may incur as a result of the use of such data.

Fusion media or anyone involved with Fusion Media will not accept any responsibility for any loss or damage resulting from reliance on any information, including data, quotes, graphics and buy / sell signals contained in this website. Please be fully informed about the risks and costs associated with trading in the financial markets, it is one of the riskiest forms of investing possible.

[ad_2]

About Nunnally Maurice

Check Also

Evonik launches commercial scale production of ceramides

Evonik began manufacturing commercial quantities of ceramides – a special class of lipids – at …